Cryopyrin associated periodic syndromes
Other Names[edit]
CAPS; Cryopyrinopathy
Clinical features[edit]
- Cryopyrin-associated periodic syndrome (CAPS) is a rare hereditary inflammatory disorder.
- Clinical features include cutaneous, neurological, ophthalmologic, and rheumatologic manifestations.
Signs and symptoms[edit]
Most common symptoms include fever, fatigue, malaise, mood disorders or failure to thrive, urticarial or maculopapular rash, myalgia, arthralgia, and/or arthritis, joint contracture, patellar overgrowth, bone deformity, bone erosion and/or osteolytic lesion, conjunctivitis and/or uveitis, optic nerve atrophy, cataract, glaucoma or impaired vision, neurosensory hearing loss, morning headache, papilloedema, and/or meningitis, seizure, hydrocephalus or mental retardation and amyloidosis.
Types[edit]
It has thee types:
- Familial cold autoinflammatory syndrome,
- Muckle-Wells syndrome, and
- Neonatal-onset multisystem inflammatory disease.
Cause[edit]
- CAPS results from a gain-of-function mutation of the NLRP3 gene coding for cryopyrin, which forms intracellular protein complexes known as inflammasomes.
- Defects of the inflammasomes lead to overproduction of interleukin-1, resulting in inflammatory symptoms seen in CAPS.
Inheritance[edit]
It is a genetic disease transmitted in an autosomal dominant manner.
Diagnosis[edit]
Diagnosis is often delayed and requires a thorough review of clinical symptoms.
Treatment[edit]
- In February 2008, rilonacept (Arcalyst) was approved for treatment of cryopyrin-assisted periodic syndromes (CAPS).
- In June 2009, canakinumab (Ilaris) was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older.
- Canakinumab is manufactured by Novartis Pharmaceuticals Corporation under brand name Ilaris.
- In May 2013, Ilaris was also approved for the treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.
NIH genetic and rare disease info[edit]
Cryopyrin associated periodic syndromes is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Cryopyrin associated periodic syndromes
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


